Marella Thorell
CIK 1826323 · See Remarks · last filed 2026-07-10
Marella Thorell is a corporate insider who has filed 26 SEC Form 4 insider transactions across 6 companies since 2021. The most recent filing, for MCRB, was dated Jul 10, 2026. Across all open-market trades the lifetime net is −$5.8K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
6
26
-$5.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MCRB | See Remarks | — | $4.80 | — | $0 | 4 | 2026-07-10 |
| Carisma Therapeutics Inc. (CARM) Delisted | Director | — | $0.00 | — | $0 | 1 | 2024-07-01 |
| ESSA Pharma Inc. (EPIX) Delisted | Director | — | $0.20 | — | $0 | 4 | 2024-03-28 |
| Evelo Biosciences, Inc. (EVLO) Delisted | Chief Financial Officer | 22,259 | $0.00 | $2 | -$25.8K | 8 | 2023-11-08 |
| GRI Bio, Inc. (VLON) Delisted | Director | 317 | $12.00 | $3.8K | $0 | 4 | 2022-12-15 |
| Centessa Pharmaceuticals plc (CNTA) Delisted | Chief Accounting Officer | 53,101 | $40.50 | $2.15M | $20.0K | 4 | 2022-03-23 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-10 | MCRB | Grant (A) | — | $0 | EDGAR |
| 2026-03-06 | MCRB | Grant (A) | — | $0 | EDGAR |
| 2025-10-15 | — | Disp (D) | −2,881 | $0 | |
| 2025-02-11 | MCRB | Grant (A) | — | $0 | EDGAR |
| 2024-07-01 | Carisma Therapeutics Inc. (CARM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-28 | ESSA Pharma Inc. (EPIX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-27 | MCRB | Grant (A) | — | $0 | EDGAR |
| 2023-11-08 | Evelo Biosciences, Inc. (EVLO) Delisted | Mixed | +4,689 | -$598 | EDGAR |
| 2023-11-03 | Evelo Biosciences, Inc. (EVLO) Delisted | Mixed | +8,501 | -$1.3K | EDGAR |
| 2023-09-13 | Evelo Biosciences, Inc. (EVLO) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.